Dr. Maxime Rousseaux joined the University of Ottawa and the uOBMRI in April. He focused on elucidating mechanisms of neurodegeneration in models of Parkinson’s Disease (PD) and stroke during his doctoral training. He returns to Ottawa after a successful stint with Dr. Huda Zogbhi’s lab at the Howard Hughes Medical Institute/BCM, where he established a PD-centered research program that employed genetic screening methods to query the genome for modifiers of toxic protein levels and toxicity. Other accomplishments include receiving a CIHR fellowship, as well as the prestigious Stanley Fahn Junior Faculty Award from the Parkinson’s Foundation.
Dr. Derek Gibbings published in Developmental Cell
Developmental Cell published Dr. Derrick Gibbings’s recent paper “Atg5 Disassociates the V1V0-ATPase to Promote Exosome Production and Tumor Metastasis Independent of Canonical Macroautophagy”. Click here to read and learn more.
Can tiny bits of cells in the blood help track the progress of spinal muscular atrophy?
From the Ottawa Hospital Media: Dr. Robin Parks was awarded $150,000 from CureSMA to see if tiny bits of cells called exosomes can be used to track how spinal muscular atrophy (SMA) progresses and responds to treatment. Dr. Parks’ team previously found that exosomes naturally released into the blood contain similar levels of SMN protein as the affected nerve and muscle cells. This funding will allow them to continue to explore the practicality and accuracy of analyzing SMN protein levels using exosomes.